Tiago Fauth Analyst PerformanceAnalyst at Raymond James FinancialTiago Fauth is a stock analyst at Raymond James Financial in the medical sector, covering 19 publicly traded companies. Over the past year, Tiago Fauth has issued 37 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Tiago Fauth's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tiago Fauth's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings50 Last 5 YearsBuy Recommendations72.00% 36 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution50RatingsDistribution of strong buy, buy, hold, and sell ratings by Tiago Fauth.RatingPercentageCount Strong Buy4.0%2 ratings Buy68.0%34 ratings Hold26.0%13 ratings Sell2.0%1 ratingsOut of 50 total stock ratings issued by Tiago Fauth at Raymond James Financial, the majority (68.0%) have been Buy recommendations, followed by 26.0% Hold, 4.0% Strong Buy, and 2.0% Sell.Best & Worst CallsBest Call000.0%INSMFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%KROSFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ19 companiesTiago Fauth, an analyst at Raymond James Financial, currently covers 19 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical19 companies100.0%Tiago Fauth of Raymond James Financial specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE15 companies78.9%MED - DRUGS2 companies10.5%MED - GENERIC DRG1 company5.3%BIOTECHNOLOGY1 company5.3% Tiago Fauth's Ratings History at Raymond James Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsIONSIonis Pharmaceuticals4/10/2026Initiated Coverage$75.28$104.00Outperform$0.0000.00% ROIPTCTPTC Therapeutics4/10/2026Initiated Coverage$70.85$108.00Outperform$0.0000.00% ROIRAPPRapport Therapeutics4/10/2026Initiated Coverage$34.22$66.00Strong-Buy$0.0000.00% ROIPTCTPTC Therapeutics4/9/2026Initiated Coverage$68.69Moderate Buy$0.0000.00% ROIRAPPRapport Therapeutics4/9/2026Initiated Coverage$34.17Strong-Buy$0.0000.00% ROIIONSIonis Pharmaceuticals4/9/2026Upgrade$76.76Moderate Buy$0.0000.00% ROIINSMInsmed12/16/2025Boost Price Target$196.92$234.00Overweight$0.0000.00% ROIPTCTPTC Therapeutics11/5/2025Boost Price Target$67.72$93.00Overweight$0.0000.00% ROIINSMInsmed10/31/2025Boost Price Target$194.22$217.00Overweight$0.0000.00% ROIINSMInsmed10/20/2025Initiated Coverage$165.76$171.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. LQDALiquidia10/20/2025Initiated Coverage$22.48$31.00Overweight$0.0000.00% ROIMNKDMannKind10/20/2025Initiated Coverage$5.47$10.00Overweight$0.0000.00% ROIPTCTPTC Therapeutics10/20/2025Initiated Coverage$65.95$73.00Overweight$0.0000.00% ROIRAREUltragenyx Pharmaceutical10/20/2025Initiated Coverage$32.63$65.00Overweight$0.0000.00% ROIUTHRUnited Therapeutics10/20/2025Initiated Coverage$433.34$414.00Underweight$0.0000.00% ROIWVEWAVE Life Sciences10/20/2025Initiated Coverage$7.81$18.00Overweight$0.0000.00% ROIWVEWAVE Life Sciences9/4/2025Lower Price Target$8.00$18.00Overweight$0.0000.00% ROIINSMInsmed9/3/2025Boost Price Target$145.30$171.00Overweight$0.0000.00% ROIUTHRUnited Therapeutics9/3/2025Boost Price Target$404.27$414.00Equal Weight$0.0000.00% ROIMNKDMannKind9/3/2025Boost Price Target$5.63$10.00Overweight$0.0000.00% ROIPTCTPTC Therapeutics8/20/2025Lower Price Target$48.30$73.00Overweight$0.0000.00% ROILQDALiquidia8/13/2025Boost Price Target$24.10$31.00Overweight$0.0000.00% ROIINSMInsmed8/12/2025Boost Price Target$122.00$140.00Overweight$0.0000.00% ROIPTCTPTC Therapeutics8/8/2025Boost Price Target$46.28$79.00Overweight$0.0000.00% ROIALNYAlnylam Pharmaceuticals8/1/2025Boost Price Target$395.93$395.00Equal Weight$0.0000.00% ROIWVEWAVE Life Sciences7/31/2025Lower Price Target$8.32$21.00Overweight$0.0000.00% ROIUTHRUnited Therapeutics7/31/2025Lower Price Target$278.91$295.00Equal Weight$0.0000.00% ROIPTCTPTC Therapeutics7/29/2025Boost Price Target$48.86$78.00Overweight$0.0000.00% ROIINSMInsmed7/22/2025Boost Price Target$103.27$130.00Overweight$0.0000.00% ROIVRNAVerona Pharma PLC American Depositary Share7/10/2025Downgrade$104.77$107.00Hold$0.0000.00% ROIRAREUltragenyx Pharmaceutical7/10/2025Lower Price Target$30.25$65.00Overweight$0.0000.00% ROIBBIOBridgeBio Pharma6/30/2025Boost Price Target$44.24$76.00Overweight$0.0000.00% ROIALNYAlnylam Pharmaceuticals6/30/2025Boost Price Target$324.99$333.00Equal Weight$0.0000.00% ROIVRNAVerona Pharma PLC American Depositary Share6/20/2025Boost Price Target$90.92$138.00Overweight$0.0000.00% ROIINSMInsmed6/11/2025Boost Price Target$90.93$119.00Overweight$0.0000.00% ROIPTCTPTC Therapeutics5/27/2025Boost Price Target$45.93$74.00Overweight$0.0000.00% ROIINZYInozyme Pharma5/16/2025Reiterated Rating$3.95$4.00Equal Weight$0.0000.00% ROIVRNAVerona Pharma PLC American Depositary Share4/30/2025Boost Price Target$72.46$107.00Overweight$0.0000.00% ROIUTHRUnited Therapeutics4/25/2025Reiterated Rating$296.42$314.00Equal Weight$000.0000.00% ROIALNYAlnylam Pharmaceuticals3/21/2025Boost Price Target$253.60$287.00Equal Weight$000.0000.00% ROITECXTectonic Therapeutic3/21/2025Lower Price Target$20.58$101.00Overweight$00.0000.00% ROIKROSKeros Therapeutics2/27/2025Lower Price Target$11.35$26.00Overweight$00.0000.00% ROIFOLDAmicus Therapeutics2/20/2025Lower Price Target$9.56$17.00Overweight$00.0000.00% ROIINSMInsmed2/19/2025Boost Price Target$81.36$107.00Overweight$000.0000.00% ROIPLRXPliant Therapeutics2/10/2025Downgrade$7.79$4.00Equal Weight$0.0000.00% ROIINZYInozyme Pharma1/13/2025Lower Price Target$1.75$11.00Overweight$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWells Fargo & CompanyMorgan StanleyJefferies Financial GroupTD CowenPiper SandlerRoth MkmWilliam BlairUBS GroupCitigroupBarclaysRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTruist FinancialRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
